| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 02/08/2012 | CN101919835B 2-乙酰氨基龙胆酸作为制备胰岛素增敏剂的用途 2-acetyl-amino acid long as the preparation of the use of insulin sensitizers |
| 02/08/2012 | CN101810806B 一种用于治疗高泌乳素血症的药物及其制备方法 A method of treating hyperprolactinemia and preparation methods for |
| 02/08/2012 | CN101641361B 四氢咪唑并[1,5-a]吡嗪类衍生物，其制备方法及其在医药上的应用 Tetrahydroimidazo [1,5-a] pyrazine derivatives, their preparation and their applications in medicine |
| 02/08/2012 | CN101623287B 一种屈螺酮类似物的治疗更年期综合症的药物组合物 Treatment of menopausal syndrome pharmaceutical composition of drospirenone analogues |
| 02/08/2012 | CN101601653B 泼尼卡酯脂质体乳膏 Nika ester liposomes cream splash |
| 02/08/2012 | CN101186940B 获得具有正确键合的胱氨酸键的胰岛素或胰岛素衍生物的方法 Cystine bonds obtained insulin or insulin derivative having correctly bonded method |
| 02/07/2012 | US8110574 Derivatives of 4-aminopiperidine and their use as a medicament |
| 02/07/2012 | US8110565 Of the ACE inhibitor ramipril; controlling the melting point by mixing with the free acid with the ramipril ethyl or methyl ester prodrug and a pressure sensitive adhesive carrier; improved pharmacokinetics; sustained release |
| 02/07/2012 | CA2568823C Vaginally administrable progesterone-containing tablets and method for preparing same |
| 02/07/2012 | CA2488535C Glucocorticoid receptor ligands for the treatment of metabolic disorders |
| 02/07/2012 | CA2486144C Compositions comprising an angiotensin receptor blocker, a calcium channel blocker and a diuretic |
| 02/07/2012 | CA2471044C Benzimidazole derivatives and their use as gnrh antagonists |
| 02/07/2012 | CA2466536C Transdermal transport of compounds |
| 02/02/2012 | WO2012014993A1 Agent for increasing translation initiation factor or translation elongation factor, and use thereof for medical purposes |
| 02/02/2012 | US20120029026 Pyridine derivative |
| 02/02/2012 | US20120029016 Indoles Useful in the Treatment of Inflammation |
| 02/02/2012 | US20120028970 Heteroarylthiomethyl pyridine derivative |
| 02/02/2012 | US20120028948 Testosterone gel and method of use |
| 02/02/2012 | US20120028926 Phosphate Management with Small Molecules |
| 02/02/2012 | US20120028895 Inhibiting Serum Response Factor (SRF) to Improve Glycemic Control |
| 02/02/2012 | US20120028893 Adenovirus 36 E4 ORF 1 Gene and Protein and Their Uses |
| 02/02/2012 | US20120027864 Coated drug delivery formulations |
| 02/02/2012 | US20120027697 Plant extracts, compositions containing same, and uses thereof |
| 02/02/2012 | US20120027690 Ph-sensitive graft copolymer, manufacturing method for same, and polymer micelles using method |
| 02/01/2012 | EP2412705A1 Novel therapeutic agent for cognitive impairment |
| 02/01/2012 | EP2411037A1 Fast-acting insulin formulation |
| 02/01/2012 | EP2081910B1 Novel compounds |
| 02/01/2012 | EP1953165B1 Aza-substituted spiro derivative |
| 02/01/2012 | EP1893182B1 Oral dosage forms comprising progesterone and method of making and using the same |
| 02/01/2012 | EP1511725B1 24-sulfoximine vitamin d3 compounds |
| 02/01/2012 | EP1286989B1 Prodrug of an ICE inhibitor |
| 02/01/2012 | CN1964989B 长效胰岛素衍生物及其方法 Long-acting insulin derivatives and methods |
| 02/01/2012 | CN102336801A Abiraterone acetate polymorphic substance and pharmaceutical composition |
| 02/01/2012 | CN102336763A Synthesis method for pyranocoumarin derivatives |
| 02/01/2012 | CN102336716A 嘧啶衍生物 Pyrimidine derivatives |
| 02/01/2012 | CN102335269A Aromatase inhibitor |
| 02/01/2012 | CN102335219A Aromatase inhibitor |
| 02/01/2012 | CN101426806B 作为选择性黄体酮受体调节剂的氧杂-甾族衍生物 As selective progesterone receptor modulators oxa - steroid derivative |
| 01/31/2012 | US8106063 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 01/31/2012 | CA2508233C New substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions |
| 01/26/2012 | WO2012012667A2 Methods and compositions for modification of a hla locus |
| 01/26/2012 | WO2012011591A1 Fused heterocyclic compound and application thereof |
| 01/26/2012 | WO2012010516A1 Growth hormone conjugates |
| 01/26/2012 | US20120022500 Compositions and Methods for Induced Brown Fat Differentiation |
| 01/26/2012 | US20120022092 Protein kinase c inhibitors and uses thereof |
| 01/26/2012 | US20120022058 4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses |
| 01/26/2012 | US20120021044 Novel Cationic Lipid, A Preparation Method of the Same and A Delivery System Comprising the Same |
| 01/26/2012 | US20120020936 Treatment of neurodegenerative disease using placental stem cells |
| 01/26/2012 | CA2806258A1 Fused heterocyclic compound and application thereof |
| 01/25/2012 | EP2409569A2 Method for administering GLP-1 molecules |
| 01/25/2012 | EP2408799A1 Novel crystalline form of antiprogestin cdb-4124 |
| 01/25/2012 | EP2408798A1 Polymorphs of fluticasone furoate and processes for preparation thereof |
| 01/25/2012 | EP1310494B1 PPAR (delta) ACTIVATORS |
| 01/25/2012 | CN102333773A Mineralocorticoid receptor antagonist and methods of use |
| 01/25/2012 | CN102327368A Chinese lizardtail rhizome or herb rootstock total effective fraction and preparation method and application thereof |
| 01/25/2012 | CN102327309A Barberry bark extractive and use of barberry bark extractive and barberry bark |
| 01/25/2012 | CN102327239A Salmon calcitonin nano liposome injection and preparation method thereof |
| 01/25/2012 | CN102166310B Preparation method of traditional Chinese medicine for treating liver and kidney Yin deficiency type hyperthyroidism |
| 01/25/2012 | CN101623432B Application of jade lady variant decoction in preparing medicament for treating hyperthyrea symptom |
| 01/25/2012 | CN101549046B Health preserving product of north Chinese Caterpillar Fungus and glossy ganoderma |
| 01/25/2012 | CN101240015B Core-peptide composition with physiological activity and its preparation method and application |
| 01/24/2012 | US8101599 Pharmaceutical composition containing anti-hypertensive agents |
| 01/24/2012 | CA2478825C Composition having gelling properties for the prolonged delivery of bioactive substances |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/19/2012 | WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 01/19/2012 | WO2012007458A1 Gene therapy composition for use in diabetes treatment |
| 01/19/2012 | WO2012007453A1 Crystalline compound of 1-[4-(2-azepan-1-ylethoxy)benzyl]-2-(4-hydroxyphenyl)-3-methyl-1h-indol-5-ol |
| 01/19/2012 | WO2012006955A1 Compounds for treatment of metabolic disorders |
| 01/19/2012 | US20120016035 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/19/2012 | US20120015957 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 01/19/2012 | US20120015936 Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs |
| 01/19/2012 | US20120015931 Purine compounds selective for pi3k p110 delta, and methods of use |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015917 Use of Estrogenic Compounds in Combination with Progestogenic Compounds in Hormone-Replacement Therapy |
| 01/19/2012 | US20120015916 Method for Treating Secondary Hyperparathyroidism in CKD |
| 01/19/2012 | US20120015913 Formulations of 14-EPI-Analogues of Vitamin D |
| 01/19/2012 | US20120014979 Use of bcl6 inhibitors for treating autoimmune diseases |
| 01/19/2012 | US20120014910 Compositions and methods for treating symptoms associated with menopause, hormonal variations and arthritis |
| 01/19/2012 | CA2805170A1 Gene therapy composition for use in diabetes treatment |
| 01/18/2012 | EP2406252A1 Mineralocorticoid receptor antagonist and methods of use |
| 01/18/2012 | EP2405934A1 Treatment of diabetes and metabolic syndrome |
| 01/18/2012 | EP2300472B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/18/2012 | EP1456385B1 Growth hormone fusion protein |
| 01/18/2012 | CN102321024A Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof |
| 01/18/2012 | CN102319422A Long - acting formulations of insulins |
| 01/18/2012 | CN102319418A Buserelin preparation and preparation method thereof |
| 01/18/2012 | CN102319267A Method for efficiently preparing bee pollen aqueous extract |
| 01/18/2012 | CN102319266A krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 01/18/2012 | CN102319216A Insulin liposome lyophilized powder, oral insulin compound preparation and preparation methods and applications thereof |
| 01/17/2012 | US8097587 IGF-I protein variants for treating IGFBP-1-related disorders |
| 01/17/2012 | US8097289 Papaya puree and the use of the same |
| 01/17/2012 | CA2517390C Chroman-derived anti-androgens for treatment of androgen-mediated disorders |
| 01/12/2012 | WO2012003784A1 Pyrazine derivatives,process for manufacture and use thereof |
| 01/12/2012 | WO2011103202A3 Androgen receptor modulators and uses thereof |
| 01/12/2012 | US20120010295 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/12/2012 | US20120010290 Methods of Treating an Overweight or Obese Subject |
| 01/12/2012 | US20120010282 Tautomycetin and Tautomycetin Analog Biosynthesis |
| 01/12/2012 | US20120010245 Transdermal pharmaceutical compositions comprising a serm |
| 01/12/2012 | US20120010156 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1 |